THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.

What Is FOXO4-D-Retro-Inverso (DRI)?

.FOXO4 is a member of a larger group of genes that produce transcription factor proteins that are important in growth and differentiation. The FOXO4 protein is modified in normal biology by post-translational activities. These modifications alter the DNA binding affinity of FOXO4 and thus allow it to regulate a host of cellular pathways such as oxidative stress signaling, cellular senescence, apoptosis, insulin signaling, and the cell cycle itself. The FOXO4 protein is found in high quantities in placenta, ovaries, testes, fat cells, and adrenal glands[1].

FOXO4 D-Retro-Inverso is identical to the protein product of the FOXO4 gene, but the normal L amino acids have been exchanged for D amino acids. The result is that FOXO4-DRI has reduced susceptibility to normal physiologic clearance mechanisms and thus remains in the body for longer periods of time. The modified protein is still capable, however, of affecting transcription and cellular pathways. In general, the FOXO4-DRI protein interferes with normal FOXO4 function.

Of greatest interest in terms of aging and senescence is the ability of FOXO4-DRI to interfere with normal FOXO4 signaling in the cell cycle by preventing the binding of FOXO4 to p53. The p53 protein is an important regulator of progression through the cell cycle as well as programmed cell death (apoptosis). When FOXO4-DRI binds to p53, it prevents FOXO4 from binding and allows p53 to bind to DNA. This, in turn, allows the cell to continue through the process of apoptosis and die. Interestingly, FOXO4-DRI appears to only have this effect in senescent cells, cells that are no longer functional or are dysfunctional as a result of aging[2]. By targeting these dysfunctional cells, FOXO4-DRI helps to rid tissue of cells that are nothing but dead weight. This, in turn, allows for better tissue functioning and helps to stimulate growth and differentiation of younger, healthier cells. The net result is better biological function and thus a decrease in “biological age”.

“DRI” Retro Inverso Peptides Explained

DRI-Retro Inverso Peptides Explained Retro-inverso peptides are linear peptides whose amino acid sequence is reversed and the α-center chirality of the amino acid subunits is inverted as well. Usually, these types of peptides are designed by including D-amino acids in the reverse sequence to help maintain side chain topology similar to that of the original L-amino acid peptide and make them more resistant to proteolytic degradation. Other reported synonyms for these peptides in the scientific literature are: Retro-Inverso Peptides, All-D-Retro Peptides, Retro-Enantio Peptides, Retro-Inverso Analogs, Retro-Inverso Analogues, Retro-Inverso Derivatives, and Retro-Inverso Isomers. D-amino acids represent conformational mirror images of natural L-amino acids occurring in natural proteins present in biological systems. Peptides that contain D-amino acids have advantages over peptides that just contain L-amino acids. In general, these types of peptides are less susceptible to proteolytic degradation and have a longer effective time when used as pharmaceuticals. Furthermore, the insertion of D-amino acids in selected sequence regions as sequence blocks containing only D-amino acids or in-between L-amino acids allows the design of peptide-based drugs that are bioactive and possess increased bioavailability in addition to being resistant to proteolysis. Furthermore, if properly designed, retro-inverso peptides can have binding characteristics similar to L-peptides. Retro-inverso peptides are useful candidates for the study of protein-protein interactions by designing peptidomimetics that mimic the shape of peptide epitopes, protein-protein, or protein-peptide interfases. Retro-inverso-peptides are attractive alternatives to L-peptides used as pharmaceuticals. These of peptide have been reported to elicit lower immunogenic responses compared to L-peptides.

FOXO4-DRI releases p53 from physiologic sequestration. The p53 protein then targets senescent cells for apoptosis. The net result is an increase in overall tissue fitness and thus improved function at the tissue and organ level. Improved tissue function is referred to as reduced biological age.

Sequence: H-D-Leu-D-Thr-D-Leu-D-Arg-D-Lys-D-Glu-D-Pro-D-Ala-D-Ser-D-Glu-D-Ile-D-Ala-D-Gln-D-Ser-D-Ile-D-Leu-D-Glu-D-Ala-D-Tyr-D-Ser-D-Gln-D-Asn-D-Gly-D-Trp-D-Ala-D-Asn-D-Arg-D-Arg-D-Ser-D-Gly-D-Gly-D-Lys-D-Arg-D-Pro-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-D-Gly-OH Molecular Formula: C228H388N86O64 Molecular Weight: 5358.05 Synonyms: Forkhead box protein O4, Proxofim, FOXO4a, AFX, AFX1, MLLT7

FOXO4-DRI Aging and Senescence

The relationship between FOXO4 and aging is complex and still not fully understood. There is, however, good evidence that helps to elucidate the mechanisms by which the protein has its effects. Research in the well-studied nematode shows that FOXO4 affects insulin-like growth factor receptor signaling and thus cellular lifespan control, stress resistance, and gene regulation. It also appears that FOXO4 interacts with the p53 protein to regulate the cell cycle.

Natural FOXO4 actually protects senescent cells by keeping p53, a regulator of the cell cycle, sequestered and unable to induce apoptosis. FOXO4-DRI disrupts the normal FOXO4/p53 mechanism and allows the latter protein to induce apoptosis in senescent cells. The result is an amelioration of senescence-associated loss of tissue homeostasis[4], [5]. Scientists refer to this as rejuvenation by therapeutic elimination of senescent cells. The process is not all that different from pruning a fruit tree. By removing dead and damaged branches (senescent cells), energy is redirected to healthier parts of the tree and thus to fruit production and growth. This same process happens at the organ and tissue level when cells that are contributing to overall unhealthy function are removed, allowing resources to be focused on healthy cells.

This image displays what factors contribute to senescence and what the outcomes are senescence are. Note that eliminating a senescent cell does not alleviate stem cell exhaustion, but may slow it down. It does, however, help to reduce chronic inflammation, a well-established driver of a number of conditions like cardiac disease, stroke, etc.

Irreparable damage, which is to say cellular damage that is beyond the ability of the body to fix, is one of the primary limitations to health span. Health span, the length of time during which an organism remains healthy and functioning optimally, is generally shorter than lifespan. A decline in healthspan manifests as aging. The ability to extend health span may not result in more years lived, but it can result in living out the years allotted to us in greater health and with better functioning. In mouse models, FOXO4 has been shown to improve health span in aged mice, leading to an increase in fitness, fur density, and renal functioning. The mice do not necessarily live longer, but they have greater health, even into old age, which translates into less disability and fewer age-related conditions like heart disease, musculoskeletal dysfunction, etc[2].

Images showing improved fitness, as indicated by fur density, in a mouse treated with FOXO4-DRI after subjected to chemotoxic agents used to model aging:

FOXO4-DRI Research

1. Insulin Signaling

It has long been understood that FOXO proteins are important regulators of insulin signaling, but that they act downstream of the insulin itself as well as insulin-like growth factors. Research in animal models indicates that FOXO mediates that inhibitor effects of insulin and insulin-like growth factor on cell metabolism, growth, differentiation, oxidative stress, and more. Mutations in FOXO are connected to pathologic changes in insulin signaling and the development of metabolic disease as well as cancer. In diabetics, alterations of FOXO signaling leads to fasting hyperglycemia and hyperlipidemia[6]. The latter is one of the most concerning aspects of diabetes as it leads to many of the complications of the disease such as kidney damage, stroke, heart attack, impaired wound healing, and more. The ability to regulate FOXO signaling in diabetes could provide for more targeted, more effective methods of preventing some of the serious complications of the disease. It is unclear how FOXO4-DRI affects insulin signaling, but it is thought that the protein can improve downstream effects of insulin by reducing fasting blood sugar levels.

2. Heart Disease

Age is a risk factor for cardiovascular disease. This risk appears to be mediated by declines in proteasome activity in the heart. Proteasomes are responsible for removing oxidized proteins and other proteins that the cell has marked as “damaged” or dysfunctional. Research in rats shows that age is inversely correlated with proteasome activity and thus increases in levels of damaged proteins within the heart[7].

FOXO proteins mediate autophagy and proteasome activity. Increases in FOXO4 levels lead to increases in proteasome activity and thus decreased levels of oxidation and protein damage within specific tissue. It may be possible that FOXO4-DRI or a variant of it can be used to boost the heart’s natural housekeeping functions and thus reduce age-related changes in cardiovascular function[8].

3. Neurodegenerative Disease

Age-related changes in cognitive function have a complex etiology. Even relatively common diseases, like Alzheimer’s disease, are not fully understood by the medical community. There is some evidence, however, to support the notion that changes in proteasome activity can lead to or exacerbate underlying neurodegenerative conditions. It isn’t clear if impaired proteasome activity is a primary cause or secondary contributor to diseases like Alzheimer’s disease, but impairment of the systems has been found in Parkinson’s, Alzheimer’s, Huntington’s, and Prion disease. There is also impairment of proteasome function in amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease) [9].

It appears that FOXO proteins are modified in the central nervous system, a finding that has led researchers to explore the idea that exogenous FOXO protein may be useful in treating or preventing neurodegenerative disorders. At the very least, there is hope that FOXO4-DRI and other modified FOXO proteins may be useful in slowing the relentless progression of neurodegenerative disorders [10].

Summary

FOXO4-DRI has been clearly demonstrated to boost apoptosis in cells that have become senescent, leading to improved tissue function and better overall health in animal models. It remains to be seen just how extensive the effects of FOXO4-DRI are, but there is hope that the protein can unlock insight into age-related conditions like dementia, heart disease, and general loss of function caused by cell senescence.

FOXO4-DRI exhibits minimal side effects, low oral and excellent subcutaneous bioavailability in mice. Per kg dosage in mice does not scale to humans. FOXO4-DRI for sale at peptide Review hub is limited to educational and scientific research only, not for human consumption. Only buy FOXO4-DRI if you are a licensed researcher.

Article Author

The above literature was researched, edited and organized by Dr. Logan, M.D. Dr. Logan holds a doctorate degree from Case Western Reserve University School of Medicine and a B.S. in molecular biology.

FOXO4-DRI (FOXO4 D-Retro-Inverso) is a synthetic senolytic research peptide that has become one of the most discussed compounds in longevity, cellular senescence, healthy aging, and regenerative biology research. Scientists investigate FOXO4-DRI for its ability to disrupt interactions between FOXO4 and p53, selectively promoting apoptosis in senescent cells while preserving healthy cellular populations.

As interest in senolytics and age-related biology continues to grow, researchers frequently compare FOXO4-DRI vendors based on purity, analytical testing, pricing, manufacturing quality, and supplier reliability.

This FOXO4-DRI Vendor Price Comparison Guide helps researchers evaluate suppliers using objective criteria including:

• Product Pricing

• Cost Per Milligram

• Product Purity

• Third-Party Testing

• Certificate of Analysis (COA)

• Vendor Reputation

• Customer Reviews

• Shipping Performance

• Product Availability

• Overall Value

Whether you're searching for the lowest-priced FOXO4-DRI supplier, vendors providing extensive laboratory verification, or the highest-purity research product, this guide provides a framework for comparing peptide suppliers.

Explore FOXO4-DRI Vendors by Criteria

Most Popular FOXO4-DRI Vendors

Compare suppliers frequently selected by aging, longevity, and senescence researchers.

Highest Reviewed FOXO4-DRI Vendors

Discover peptide companies with strong customer satisfaction and positive marketplace reputations.

Lowest Price FOXO4-DRI Vendors

Identify suppliers offering competitive pricing and favorable cost-per-milligram value.

Highest Purity FOXO4-DRI Vendors

Review suppliers providing transparent purity verification and batch-specific testing.

Best Value FOXO4-DRI Vendors

Compare testing standards, product quality, customer support, and pricing.

Fastest Shipping FOXO4-DRI Vendors

Evaluate fulfillment speed, packaging quality, and shipping reliability.

Newly Listed FOXO4-DRI Vendors

Explore recently launched suppliers offering FOXO4-DRI research products.

What Is FOXO4-DRI?

Overview

FOXO4-DRI is a modified version of the FOXO4 peptide designed using D-retro-inverso (DRI) peptide technology.

Researchers investigate FOXO4-DRI because of its potential role in:

• Cellular senescence research

• Senolytic biology

• Aging mechanisms

• Tissue homeostasis

• Cellular apoptosis

• Longevity science

• Regenerative biology

• Age-related functional decline

The peptide has generated substantial interest because of its apparent ability to selectively target senescent cells while leaving healthy cells largely unaffected in experimental models.

Molecular Characteristics

Peptide Information

Researchers evaluating FOXO4-DRI products should carefully review available analytical documentation and product specifications.

Peptide Name

FOXO4-DRI

Alternative Names

• FOXO4 D-Retro-Inverso

• Proxofim

• FOXO4 Senolytic Peptide

• FOXO4a

• AFX

• AFX1

• MLLT7

Molecular Formula

C228H388N86O64

Molecular Weight

5358.05 g/mol

Classification

Synthetic Senolytic Peptide

Research Category

Longevity & Senescence Research

Understanding D-Retro-Inverso Peptides

What Does DRI Mean?

D-retro-inverso peptides are engineered peptides in which:

• Amino-acid sequences are reversed

• Natural L-amino acids are replaced with D-amino acids

• Biological stability is increased

• Resistance to enzymatic degradation is improved

Researchers use DRI technology because it often enhances peptide stability while preserving biological activity.

This approach has made FOXO4-DRI a particularly attractive candidate for longevity and cellular-aging research.

Why Researchers Compare FOXO4-DRI Vendors

Research reproducibility depends heavily on peptide quality and manufacturing consistency.

Differences among suppliers may include:

• Purity levels

• Batch consistency

• Manufacturing standards

• Stability testing

• Identity verification

• Product documentation

• Storage conditions

• Shipping procedures

Careful vendor selection helps improve research reliability and reproducibility.

How We Compare FOXO4-DRI Vendors

Third-Party Laboratory Testing

Independent testing remains one of the strongest indicators of product quality.

Researchers should prioritize suppliers offering:

• Third-party testing

• Identity verification

• Purity analysis

• Batch-specific reports

Certificate of Analysis (COA)

A quality COA should include:

• Batch number

• Testing date

• Purity results

• Identity confirmation

• Analytical methodologies

Product Purity

Purity remains one of the most important variables when evaluating research peptides.

Higher-purity preparations may contribute to improved consistency and reproducibility.

Cost Per Milligram

Comparing only product prices may produce misleading conclusions.

Cost Per Milligram Formula

Product Price ÷ Total Milligrams = Cost Per Milligram

This allows researchers to compare suppliers more accurately.

Customer Reviews

Customer feedback often provides insight regarding:

• Product consistency

• Packaging quality

• Delivery performance

• Customer support

• Purchasing experience

Vendor Reputation

Established peptide suppliers often demonstrate:

• Reliable quality-control systems

• Transparent testing practices

• Positive customer satisfaction

• Consistent inventory availability

Current Research & Evidence

Cellular Senescence Research

The primary focus of FOXO4-DRI research involves cellular senescence.

Researchers continue investigating mechanisms involving:

• Senescent-cell accumulation

• Tissue dysfunction

• Cellular aging pathways

• Age-related biological decline

This remains the central area of FOXO4-DRI investigation.

Senolytic Research

FOXO4-DRI is widely regarded as one of the most prominent senolytic research peptides.

Scientists continue studying its potential relationship with:

• Selective senescent-cell removal

• Cellular turnover

• Tissue rejuvenation pathways

• Maintenance of healthy cellular populations

FOXO4 and p53 Research

A major focus of FOXO4-DRI studies involves interactions between:

• FOXO4 signaling pathways

• p53-mediated apoptosis

• Cell-cycle regulation

• Cellular repair mechanisms

Researchers believe these pathways help explain much of FOXO4-DRI's observed activity in experimental models.

Key Findings on FOXO4-DRI Research

Apoptosis Research

Experimental studies have examined FOXO4-DRI's potential relationship with:

• Programmed cell death

• Senescent-cell clearance

• Cellular lifecycle regulation

• Tissue maintenance

Researchers continue exploring these mechanisms in aging models.

Tissue Homeostasis Research

Accumulation of dysfunctional cells can impair normal tissue function.

Scientists investigate how FOXO4-DRI may influence:

• Tissue maintenance

• Cellular renewal

• Structural integrity

• Organ-system function

This remains a key area of senescence research.

Aging Research

FOXO4-DRI has attracted widespread attention in longevity science because of its relationship with:

• Healthy aging

• Functional longevity

• Biological-age pathways

• Age-related decline

Researchers continue exploring how senescent-cell biology influences overall organism function.

Inflammation Research

Senescent cells are often associated with inflammatory signaling.

Researchers continue studying whether FOXO4-DRI-related pathways may influence:

• Chronic inflammation

• Cellular signaling

• Tissue stress responses

• Age-associated inflammatory processes

Organ Function Research

Experimental models have investigated FOXO4-DRI in relation to:

• Renal function

• Cardiovascular health

• Connective tissue maintenance

• Organ-system resilience

This remains an emerging field of investigation.

Additional Areas of Research

Insulin Signaling Research

FOXO proteins play important roles in pathways involving:

• Insulin signaling

• Metabolic regulation

• Cellular energy utilization

• Growth-factor signaling

Researchers continue examining how FOXO4-related mechanisms affect metabolic biology.

Cardiovascular Research

Studies have explored relationships between FOXO pathways and:

• Cardiac aging

• Cellular stress responses

• Proteasome activity

• Cardiovascular function

Additional research remains ongoing.

Neurodegenerative Disease Research

Researchers continue evaluating FOXO-related mechanisms in studies involving:

• Cognitive aging

• Protein homeostasis

• Neurodegeneration

• Cellular maintenance pathways

This remains a growing field of scientific interest.

Research Limitations

Most FOXO4-DRI findings originate from:

• Laboratory investigations

• Cell-culture research

• Animal models

• Early-stage longevity studies

Additional research is needed to fully characterize FOXO4-DRI's mechanisms and long-term biological effects.

Research findings should not be interpreted as evidence of approved therapeutic applications.

Product Quality & Analytical Testing

Why Testing Matters

Research-grade FOXO4-DRI products should undergo testing to verify:

• Identity

• Purity

• Stability

• Potency

• Batch consistency

Common Testing Methods

High-Performance Liquid Chromatography (HPLC)

Used to determine purity and identify impurities.

Mass Spectrometry (MS)

Used to verify molecular identity and peptide composition.

Identity Verification Testing

Confirms peptide authenticity.

Stability Testing

Measures peptide integrity during storage.

Batch Consistency Testing

Evaluates reproducibility across manufacturing lots.

Understanding FOXO4-DRI Pricing

Several factors influence FOXO4-DRI pricing.

Complex Peptide Synthesis

FOXO4-DRI contains a lengthy amino-acid sequence and specialized D-amino-acid modifications.

These manufacturing requirements often increase production costs.

Product Purity

Higher-purity products generally command premium pricing.

Analytical Verification

Comprehensive testing programs improve transparency but increase manufacturing expenses.

Specialty Research Demand

FOXO4-DRI remains a highly specialized senolytic peptide with relatively limited production volume.

Vendor Reputation

Trusted suppliers often charge more due to established quality-assurance procedures.

FOXO4-DRI Vendor Evaluation Checklist

Quality Verification

✅ Third-party testing available

✅ Certificate of Analysis provided

✅ Identity verification documented

✅ Purity information disclosed

✅ Batch-specific testing available

Vendor Reliability

✅ Positive customer reviews

✅ Transparent company information

✅ Responsive customer support

✅ Reliable inventory availability

Purchasing Experience

✅ Secure checkout process

✅ Shipment tracking available

✅ Clear refund policies

✅ Reliable order fulfillment

Red Flags When Comparing Vendors

Testing Concerns

❌ No third-party testing

❌ Missing COAs

❌ Unverified purity claims

❌ Outdated laboratory reports

Transparency Issues

❌ Hidden product specifications

❌ Missing batch information

❌ Limited documentation

❌ No company contact information

Service Problems

❌ Frequent stock shortages

❌ Poor communication

❌ Negative customer reviews

❌ Unclear shipping policies

How to Choose the Best FOXO4-DRI Vendor

Prioritize Independent Testing

Choose suppliers providing third-party testing and batch-specific Certificates of Analysis.

Verify Peptide Purity

Because FOXO4-DRI is a highly complex peptide, purity verification is especially important.

Evaluate Overall Value

Balance pricing against documentation quality, testing standards, and supplier reputation.

Review Product Documentation

Verify identity and analytical reports before purchasing.

Match Products to Research Requirements

Select suppliers whose quality standards align with laboratory objectives.

Frequently Asked Questions

What is FOXO4-DRI?

FOXO4-DRI is a synthetic D-retro-inverso peptide studied primarily for its role in cellular senescence, senolytic biology, aging research, and p53-associated pathways.

What is FOXO4-DRI used for in research?

Researchers investigate FOXO4-DRI in studies involving senescent-cell clearance, apoptosis, tissue homeostasis, longevity science, cellular aging, and FOXO4/p53 signaling.

Why compare FOXO4-DRI vendors?

Purity, analytical testing, documentation quality, pricing, and supplier reliability can vary substantially among vendors.

What should researchers review before purchasing?

Researchers should evaluate:

• Certificate of Analysis

• Purity testing

• Third-party verification

• Identity confirmation

• Vendor reputation

• Customer reviews

Why is third-party testing important?

Independent laboratory testing helps verify product identity, purity, and consistency while improving transparency.

Is the cheapest supplier always the best option?

No. Product quality, testing standards, documentation, and supplier reliability are often more important than price alone.

How often should vendor comparisons be updated?

Pricing, inventory levels, testing reports, and supplier policies can change frequently and should be reviewed regularly.

Final Thoughts

FOXO4-DRI remains one of the most prominent senolytic research peptides because of its unique relationship with cellular senescence, apoptosis pathways, and healthy-aging research. Its ability to influence FOXO4-p53 signaling has made it a major focus of studies exploring tissue maintenance, biological aging, cellular turnover, and age-related decline.

When comparing FOXO4-DRI vendors, researchers should prioritize purity verification, third-party testing, Certificate of Analysis availability, supplier reputation, and overall value rather than focusing solely on cost. A structured vendor-comparison process can help identify suppliers capable of meeting rigorous research-quality standards.